Figuerola Group, Inc. dba Figuerola Laboratories – FDA 483, Feb 28, 2023
Figueroa Group, Inc. dba Figueroa Laboratories in Buellton, CA, was inspected by the FDA, resulting in seven observations primarily concerning inadequate quality control for dietary supplements. The firm failed to establish proper specifications for finished products and components, did not qualify suppliers, and exhibited poor sanitation practices. Additionally, deficiencies were noted in master manufacturing records and batch production records, indicating significant gaps in their manufacturing process controls.
- Inspection date
- February 28, 2023
- Product type
- other
ID · 0f6e20af-50b0-4f96-a83a-4a5d23f0a6e5
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.